Robert Samuel Langer Institute Professor, Massachusetts Institute of Technology Carl June Richard W. Vague Professor in Immunotherapy, University of Pennsylvania Phil S. Baran Darlene Shiley Professor, The Scripps Research Institute David Baltimore President Emeritus and Robert Andrews Millikan Professor of Biology, California Institute of Technology Nicholas A. Peppas Nicholas A. Peppas Professor and Director of the Institute for Biomaterials, Drug Delivery and Regenerative Medicine, The University of Texas at Austin Shinya Yamanaka Director and Professor, Center for iPS Cell Research and Application (CiRA), Kyoto University Joseph Schlessinger William H. Prusoff Professor and Chairman of the Pharmacology Department, Yale School of Medicine; Director, Yale Cancer Biology Institute Christopher J. H. Porter Professor, Monash Institute of Pharmaceutical Sciences, Monash University Suzanne Farid Professor of Bioprocess Systems Engineering, University College London Chas Bountra Professor of Translational Medicine, Director of Structural Genomics Consortium; Director of Oxford Martin School, University of Oxford David Bentley Vice President and Chief Scientist, Illumina Jonathan Bones Principal Investigator, NIBRT Characterization and Comparability Laboratory, NIBRT – The National Institute for Bioprocessing Research and Training Jonas Bostrom Principal Scientist, AstraZeneca Meindert Danhof Professor of Pharmacology, Leiden University Kenneth Getz Associate Professor and Director, Center for the Study of Drug Development, Tufts University School of Medicine; Founder and Board Chair, CISCRP Helen H. Hobbs Professor, Internal Medicine and Molecular Genetics, and Director, Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center Aaron Kesselheim Associate Professor, Medicine, Harvard Medical School; Director, Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital Claus-Michael Lehr Head, Department of Drug Delivery, Helmholtz-Institute for Pharmaceutical Research Saarland, Helmholtz Center for Infection Research (HZI), Saarland University Pauline Rudd Principal Investigator, NIBRT – The National Institute for Bioprocessing Research and Training, Ireland Dolores Schendel CEO and Chief Scientific Officer, Medigene AG Peter Seeberger Director, Max-Planck-Institute of Colloids and Interfaces, and Professor, Free University of Berlin Andreas Seidel-Morgenstern Director, Department of Physical and Chemical Foundation of Process Engineering, Max Planck Institute for Dynamics of Complex Technical Systems Michael Sofia Chief Scientific Officer, Arbutus Biopharma John Talley Chief Scientific Officer, Euclises Pharmaceuticals Harold Varmus Lewis Thomas University Professor, Weill Cornell Medical College
